BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25897952)

  • 1. Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations.
    Ganguly D; Chen J
    PLoS Comput Biol; 2015 Apr; 11(4):e1004247. PubMed ID: 25897952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations.
    Liu X; Chen J
    Pac Symp Biocomput; 2020; 25():195-206. PubMed ID: 31797597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Structures and Transient Long-Range Interactions of p53 Transactivation Domain: Assessment of Explicit Solvent Protein Force Fields.
    Liu X; Chen J
    J Chem Theory Comput; 2019 Aug; 15(8):4708-4720. PubMed ID: 31241933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
    Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
    J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
    Ithuralde RE; Turjanski AG
    PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Accurate Coarse-Grained Simulations of Disordered Proteins and Their Dynamic Interactions.
    Zhang Y; Liu X; Chen J
    J Chem Inf Model; 2022 Sep; 62(18):4523-4536. PubMed ID: 36083825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich hydrophobic clusters promote folding of the N-terminus of the intrinsically disordered transactivation domain of p53.
    Espinoza-Fonseca LM
    FEBS Lett; 2009 Feb; 583(3):556-60. PubMed ID: 19162020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomistic details of the disordered states of KID and pKID. Implications in coupled binding and folding.
    Ganguly D; Chen J
    J Am Chem Soc; 2009 Apr; 131(14):5214-23. PubMed ID: 19278259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic Polarization at the Interface between the p53 Transactivation Domain and Two Binding Partners.
    Corrigan AN; Lemkul JA
    J Phys Chem B; 2022 Jul; 126(26):4814-4827. PubMed ID: 35749260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of p53 N-terminal transactivation domain 2 conformation ensemble and kinetics by phosphorylation.
    Zhao L; Ouyang Y; Li Q; Zhang Z
    J Biomol Struct Dyn; 2020 Jun; 38(9):2613-2623. PubMed ID: 31248328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replica exchange with guided annealing for accelerated sampling of disordered protein conformations.
    Zhang W; Chen J
    J Comput Chem; 2014 Sep; 35(23):1682-9. PubMed ID: 24995857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
    Okuda M; Nishimura Y
    J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative prediction of ensemble dynamics, shapes and contact propensities of intrinsically disordered proteins.
    Yu L; Brüschweiler R
    PLoS Comput Biol; 2022 Sep; 18(9):e1010036. PubMed ID: 36084124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale ensemble modeling of intrinsically disordered proteins: p53 N-terminal domain.
    Terakawa T; Takada S
    Biophys J; 2011 Sep; 101(6):1450-8. PubMed ID: 21943426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual structures, conformational fluctuations, and electrostatic interactions in the synergistic folding of two intrinsically disordered proteins.
    Zhang W; Ganguly D; Chen J
    PLoS Comput Biol; 2012 Jan; 8(1):e1002353. PubMed ID: 22253588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural ensemble of an intrinsically disordered polypeptide.
    Mittal J; Yoo TH; Georgiou G; Truskett TM
    J Phys Chem B; 2013 Jan; 117(1):118-24. PubMed ID: 23205890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.